Cargando…
Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy
PURPOSE: To examine the relationship between the number of tumour draining sentinel nodes (SNs) and pathoanatomical outcomes, in muscle-invasive bladder cancer (MIBC), in patients undergoing neoadjuvant chemotherapy (NAC) and radical cystectomy (RC). MATERIALS AND METHODS: In an ongoing prospective...
Autores principales: | Alvaeus, Julia, Rosenblatt, Robert, Johansson, Markus, Alamdari, Farhood, Jakubczyk, Tomasz, Holmström, Benny, Hemdan, Tammer, Huge, Ylva, Aljabery, Firas, Gabrielsson, Susanne, Riklund, Katrine, Winqvist, Ola, Sherif, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423786/ https://www.ncbi.nlm.nih.gov/pubmed/31760442 http://dx.doi.org/10.1007/s00345-019-03025-w |
Ejemplares similares
-
Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report
por: Rosenblatt, Robert, et al.
Publicado: (2016) -
Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Rydell, Harriet, et al.
Publicado: (2022) -
A Retrospective Analysis of the De Ritis Ratio in Muscle Invasive Bladder Cancer, with Focus on Tumor Response and Long-Term Survival in Patients Receiving Neoadjuvant Chemotherapy and in Chemo Naïve Cystectomy Patients—A Study of a Clinical Multicentre Database
por: Eriksson, Victoria, et al.
Publicado: (2022) -
The Risk of Thromboembolism in Patients with Muscle Invasive Bladder Cancer before and after Cystectomy Depending on Blood Group and Neoadjuvant Chemotherapy—A Multicentre Retrospective Cohort Study
por: Schulz Hägersten, Emma, et al.
Publicado: (2023) -
Increased CD4(+) T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients
por: Ahlén Bergman, Emma, et al.
Publicado: (2018)